15% azelaic acid acne cream
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
84148-010 -
Package NDC
84148-010-01 -
SPL ID
4c67351e-1260-cbf2-e063-6394a90ac443 -
SPL set ID
234ce15d-99e5-c687-e063-6394a90a8357 -
UNII
9RES347CKG -
UNII
0022LFJ74Y -
UNII
CQ2F5O6YIY -
UNII
4YS74Q4G4J -
UNII
PKO39VY215 -
UNII
F2VW3D43YT -
UNII
H41B6Q1I9L -
UNII
8TY5YO42NJ -
UNII
RWW266YE9I
What the source publishes
- Labeler
- Guangzhou Ariel Biotech Co., Ltd.
- Active ingredients
- 15% azelaic acid acne cream
- Form
- CREAM
- Routes
- CUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- UNAPPROVED DRUG OTHER
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
- 15% azelaic acid acne cream
- LAVANDIN OIL
- TARAXACUM OFFICINALE LEAF
- MADECASSOSIDE
- CENTELLA ASIATICA TRITERPENOIDS
- ASIATICOSIDE
- AZELAIC ACID
- O-CYMEN-5-OL
- CAPRYLOYL GLYCINE
- HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
Complete source data
{
"name": "15% azelaic acid acne cream",
"splId": "4c67351e-1260-cbf2-e063-6394a90ac443",
"labels": [
{
"setId": "234ce15d-99e5-c687-e063-6394a90a8357",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=234ce15d-99e5-c687-e063-6394a90a8357",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=234ce15d-99e5-c687-e063-6394a90a8357"
}
],
"routes": [
"CUTANEOUS"
],
"labeler": "Guangzhou Ariel Biotech Co., Ltd.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 g in 1 BOTTLE (84148-010-01)",
"package_ndc": "84148-010-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20240930"
}
],
"productId": "84148-010_4c67351e-1260-cbf2-e063-6394a90ac443",
"useDomain": "unknown",
"dosageForm": "CREAM",
"productNdc": "84148-010",
"deaSchedule": null,
"genericName": "15% azelaic acid acne cream",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LAVANDIN OIL",
"strength": ".03 g/100g"
},
{
"name": "TARAXACUM OFFICINALE LEAF",
"strength": ".01 g/100g"
},
{
"name": "MADECASSOSIDE",
"strength": ".055 g/100g"
},
{
"name": "CENTELLA ASIATICA TRITERPENOIDS",
"strength": ".03 g/100g"
},
{
"name": "ASIATICOSIDE",
"strength": ".015 g/100g"
},
{
"name": "AZELAIC ACID",
"strength": "15 g/100g"
},
{
"name": "O-CYMEN-5-OL",
"strength": ".09 g/100g"
},
{
"name": "CAPRYLOYL GLYCINE",
"strength": ".15 g/100g"
},
{
"name": "HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID",
"strength": ".5 g/100g"
}
],
"applicationNumber": null,
"marketingCategory": "UNAPPROVED DRUG OTHER",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240923",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"nui": [
"N0000008841",
"N0000009982"
],
"unii": [
"9RES347CKG",
"0022LFJ74Y",
"CQ2F5O6YIY",
"4YS74Q4G4J",
"PKO39VY215",
"F2VW3D43YT",
"H41B6Q1I9L",
"8TY5YO42NJ",
"RWW266YE9I"
],
"spl_set_id": [
"234ce15d-99e5-c687-e063-6394a90a8357"
],
"pharm_class_pe": [
"Decreased Protein Synthesis [PE]",
"Decreased Sebaceous Gland Activity [PE]"
],
"manufacturer_name": [
"Guangzhou Ariel Biotech Co., Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:84148-010_4c67351e-1260-cbf2-e063-6394a90ac443"